Great Lakes Advisors, LLC Adaptive Biotechnologies Corp Transaction History

Great Lakes Advisors, LLC

  • $11.1 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 11, 2021
SELL
$32.22 - $44.59 $10.7 Million - $14.9 Million
-333,152 Closed
0 $0
Q1 2021

May 03, 2021
BUY
$37.26 - $67.74 $689,682 - $1.25 Million
18,510 Added 5.88%
333,152 $13.4 Million
Q4 2020

Feb 09, 2021
SELL
$45.01 - $65.47 $459,642 - $668,579
-10,212 Reduced 3.14%
314,642 $18.6 Million
Q3 2020

Nov 04, 2020
BUY
$35.79 - $48.81 $11.6 Million - $15.9 Million
324,854 New
324,854 $15.8 Million

Others Institutions Holding ADPT

# of Institutions
201
Shares Held
146M
Call Options Held
68.8K
Put Options Held
42.5K
View Full List

About Adaptive Biotechnologies Corp

ADPT Quotes by TradingView
  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $670M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Great Lakes Advisors, LLC Portfolio

Follow Great Lakes Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Lakes Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email